While it is clearly documented that aneuploidy and CIN, induced by mutations in genes that control genome integrity, can instigate tumorigenesis, our results support the idea that in later stages of tumor progression, increased aneuploidy may be a consequence of tumor progression, when mutations or altered gene expression provide cancer cells with migratory and invasion capabilities through the dysfunction of the cytoskeletal proteins. This evidence concerns the gene DNM2 and cancer.